Bladder Cancer - Results from #400

Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancer, "Beyond the Abstract," by Richard B. Wilder, MD, MS, MBA October 2, 2014

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer, "Beyond the Abstract," by Mark T. W. Teo, BMedSci(Hons), BMBS, MRCP(UK), FRCR, PhD September 17, 2014

Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma, "Beyond the Abstract," by Maria M. Picken, MD, PhD, et al September 12, 2014

Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery for bladder cancer, "Beyond the Abstract," by Agnieszka Latosinska, Maria Frantzi, Leif Flühe, and Harald Mischak August 5, 2014

Risk factors and incidence of parastomal hernia in patients undergoing radical cystectomy and ileal conduit diversion, "Beyond the Abstract," by Paul T. Gellhaus, MD and Michael O. Koch, MD July 30, 2014

Developing pathways in bladder cancer care: The value and challenges of neoadjuvant chemotherapy administration, "Beyond the Abstract," by Matthew Mossanen, MD and Jonathan L. Wright, MD, MS July 22, 2014

Preliminary study results show promise in hypofractionated intensity-modulated radiation therapy with curative intent trimodality therapy for elderly patients diagnosed with MIBC, "Beyond the Abstract," by Guy Anne Turgeon, MD and Luis Souhami, MD, FASTRO July 22, 2014

New targeted therapies in the management of urothelial carcinoma of the bladder, "Beyond the Abstract," by Philippe E. Spiess, MD, MSc, FACS, FRCS(C) June 19, 2014

Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients reveals novel biomarker candidates, "Beyond the Abstract," by Yi-Ting Chen, PhD June 14, 2014

The natural history of symptoms, over time, in patients with bladder cancer undergoing radical cystectomy, "Beyond the Abstract," by Carly Benner, MD, MPH June 13, 2014

Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: A useful surrogate, "Beyond the Abstract," by Hugh J. Lavery, MD June 6, 2014

A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al June 4, 2014

The application of neoadjuvant/induction combination chemotherapy (NIC), followed by surgery, for node positive bladder cancer, "Beyond the Abstract," by Richard P. Meijer, MD, PhD, FEBU May 8, 2014

Examining survivors' burden and unmet needs in muscle-invasive bladder cancer: "Beyond the Abstract," by Sailaja Pisipati and Nihal E. Mohamed April 25, 2014

Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma, "Beyond the Abstract," by Paula Oliveira April 8, 2014

A prospective, randomized study comparing Impact LigaSure vs. a stapling device to limit blood loss associated with radical cystectomy, "Beyond the Abstract," by Stephen F. Kappa, MD, MBA March 11, 2014

Long-term functional outcomes in patients with a W-shaped ileal orthotopic neobladder with no antireflux mechanism, "Beyond the Abstract," by Andrea Minervini, MD, PhD February 22, 2014

Genetic polymorphisms in matrix metalloproteinases and tissue inhibitors of MPs, and bladder cancer susceptibility, "Beyond the Abstract," by Edyta Wieczorek and Edyta Reszka February 11, 2014

Narrow band imaging cystoscopy and bipolar electrosurgery in non-muscle invasive bladder cancer management, "Beyond the Abstract," by Bogdan Geavlete, MD, PhD January 16, 2014

Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer? "Beyond the Abstract," by Evangelos Mazaris, MD, MSc, PhD, FEBU January 8, 2014

Page 21 of 26